TreeWAS – Variant ID: rs9637932

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	1.000	0.000	0.000
# Top node	1.000	0.000	0.000
Chapter XX External causes of morbidity and mortality	1.000	0.000	0.000
Chapter VI Diseases of the nervous system	0.999	0.001	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.999	0.001	0.000
Chapter II Neoplasms	0.998	0.002	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.997	0.003	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.992	0.008	0.000
Chapter I Certain infectious and parasitic diseases	0.991	0.009	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.990	0.010	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.988	0.012	0.000
Chapter XXI Factors influencing health status and contact with health services	0.985	0.015	0.000
Z40-Z54 Persons encountering health services for specific procedures and health care	0.985	0.015	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.984	0.016	0.000
C78.0 Secondary malignant neoplasm of lung	0.981	0.019	0.000
Z50 Care involving use of rehabilitation procedures	0.981	0.019	0.000
C79 Secondary malignant neoplasm of other sites	0.974	0.026	0.000
Z50.1 Other physical therapy	0.970	0.030	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.969	0.031	0.000
I60-I69 Cerebrovascular diseases	0.965	0.035	0.000
Chapter IX Diseases of the circulatory system	0.962	0.038	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.961	0.039	0.000
B95-B98 Bacterial, viral and other infectious agents	0.956	0.044	0.000
C77.2 Intra-abdominal lymph nodes	0.954	0.046	0.000
I69 Sequelae of cerebrovascular disease	0.953	0.047	0.000
G40-G47 Episodic and paroxysmal disorders	0.953	0.047	0.000
G81 Hemiplegia	0.945	0.055	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.943	0.057	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.943	0.057	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.943	0.057	0.000
Z70-Z76 Persons encountering health services in other circumstances	0.940	0.060	0.000
Z51 Other medical care	0.937	0.063	0.000
I61 Intracerebral haemorrhage	0.930	0.070	0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.930	0.070	0.000
C79.6 Secondary malignant neoplasm of ovary	0.927	0.073	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.926	0.074	0.000
Y45.1 Salicylates	0.925	0.075	0.000
I05-I09 Chronic rheumatic heart diseases	0.922	0.078	0.000
C77.1 Intrathoracic lymph nodes	0.919	0.081	0.000
Z51.2 Other chemotherapy	0.915	0.085	0.000
G81.9 Hemiplegia, unspecified	0.911	0.089	0.000
C77.8 Lymph nodes of multiple regions	0.906	0.094	0.000
I69.3 Sequelae of cerebral infarction	0.904	0.096	0.000
G44 Other headache syndromes	0.900	0.100	0.000
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.897	0.103	0.000
C92 Myeloid leukaemia	0.897	0.103	0.000
C78.7 Secondary malignant neoplasm of liver	0.897	0.103	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.895	0.105	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.894	0.106	0.000
G82 Paraplegia and tetraplegia	0.892	0.108	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.892	0.108	0.000
I05 Rheumatic mitral valve diseases	0.892	0.108	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.892	0.108	0.000
G83 Other paralytic syndromes	0.888	0.112	0.000
Z40 Prophylactic surgery	0.885	0.115	0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.883	0.117	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.882	0.118	0.000
W50-W64 Exposure to animate mechanical forces	0.877	0.123	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.872	0.128	0.000
Y86 Sequelae of other accidents	0.868	0.132	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.868	0.132	0.000
B97 Viral agents as the cause of diseases classified to other chapters	0.868	0.132	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.862	0.138	0.000
Z50.5 Speech therapy	0.862	0.138	0.000
V80-V89 Other land transport accidents	0.861	0.139	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.860	0.140	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.858	0.142	0.000
I05.9 Mitral valve disease, unspecified	0.855	0.145	0.000
Q50-Q56 Congenital malformations of genital organs	0.855	0.145	0.000
B25-B34 Other viral diseases	0.855	0.145	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.842	0.158	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.841	0.159	0.000
Z75 Problems related to medical facilities and other health care	0.841	0.159	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.840	0.160	0.000
C77.0 Lymph nodes of head, face and neck	0.840	0.160	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.839	0.161	0.000
Z73 Problems related to life-management difficulty	0.838	0.162	0.000
G44.2 Tension-type headache	0.838	0.162	0.000
G35 Multiple sclerosis	0.832	0.168	0.000
Z51.0 Radiotherapy session	0.830	0.170	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.827	0.173	0.000
A30-A49 Other bacterial diseases	0.823	0.177	0.000
V40-V49 Car occupant injured in transport accident	0.821	0.179	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.821	0.179	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.820	0.180	0.000
I67 Other cerebrovascular diseases	0.815	0.185	0.000
Y57 Other and unspecified drugs and medicaments	0.812	0.188	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.811	0.189	0.000
Z46 Fitting and adjustment of other devices	0.808	0.192	0.000
Y45.0 Opioids and related analgesics	0.808	0.192	0.000
B02 Zoster [herpes zoster]	0.807	0.193	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.806	0.194	0.000
C77.9 Lymph node, unspecified	0.803	0.197	0.000
X50-X57 Overexertion, travel and privation	0.802	0.198	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.802	0.198	0.000
G83.4 Cauda equina syndrome	0.800	0.200	0.000
Y00-Y09 Assault	0.799	0.201	0.000
Z43 Attention to artificial openings	0.796	0.204	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.794	0.206	0.000
X10-X19 Contact with heat and hot substances	0.793	0.207	0.000
Z52 Donors of organs and tissues	0.790	0.210	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.789	0.211	0.000
X60-X84 Intentional self-harm	0.785	0.215	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.784	0.216	0.000
Q80-Q89 Other congenital malformations	0.781	0.219	0.000
G43 Migraine	0.779	0.221	0.000
Y85 Sequelae of transport accidents	0.777	0.223	0.000
W20-W49 Exposure to inanimate mechanical forces	0.776	0.224	0.000
C77.5 Intrapelvic lymph nodes	0.773	0.227	0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.772	0.228	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.770	0.230	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.770	0.230	0.000
V01-V09 Pedestrian injured in transport accident	0.769	0.231	0.000
I60 Subarachnoid haemorrhage	0.769	0.231	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.767	0.233	0.000
B08.1 Molluscum contagiosum	0.764	0.236	0.000
Y43 Primarily systemic agents	0.761	0.239	0.000
G80 Infantile cerebral palsy	0.759	0.241	0.000
C92.7 Other myeloid leukaemia	0.758	0.242	0.000
Z47 Other orthopaedic follow-up care	0.758	0.242	0.000
Q21 Congenital malformations of cardiac septa	0.757	0.243	0.000
C80 Malignant neoplasm without specification of site	0.757	0.243	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.753	0.247	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.753	0.247	0.000
I65.2 Occlusion and stenosis of carotid artery	0.752	0.248	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.748	0.252	0.000
G47 Sleep disorders	0.747	0.253	0.000
C92.1 Chronic myeloid leukaemia	0.745	0.255	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.745	0.255	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.745	0.255	0.000
C95 Leukaemia of unspecified cell type	0.744	0.256	0.000
Q00-Q07 Congenital malformations of the nervous system	0.744	0.256	0.000
G82.5 Tetraplegia, unspecified	0.744	0.256	0.000
Q38-Q45 Other congenital malformations of the digestive system	0.742	0.257	0.000
A80-A89 Viral infections of the central nervous system	0.742	0.258	0.000
G82.4 Spastic tetraplegia	0.741	0.259	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.739	0.261	0.000
Z75.1 Person awaiting admission to adequate facility elsewhere	0.738	0.262	0.000
B25 Cytomegaloviral disease	0.738	0.262	0.000
C77.4 Inguinal and lower limb lymph nodes	0.738	0.262	0.000
Z71.9 Counselling, unspecified	0.738	0.262	0.000
B01 Varicella [chickenpox]	0.737	0.263	0.000
C79.2 Secondary malignant neoplasm of skin	0.736	0.263	0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.736	0.264	0.000
I07 Rheumatic tricuspid valve diseases	0.735	0.265	0.000
G43.1 Migraine with aura [classical migraine]	0.734	0.266	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.734	0.266	0.000
I05.0 Mitral stenosis	0.734	0.266	0.000
B96.6 Bacillus fragilis [B. fragilis] as the cause of diseases classified to other chapters	0.734	0.266	0.000
G03 Meningitis due to other and unspecified causes	0.732	0.267	0.000
I63 Cerebral infarction	0.731	0.269	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.731	0.269	0.000
Y45.2 Propionic acid derivatives	0.730	0.270	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.730	0.270	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.729	0.271	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.728	0.272	0.000
G70-G73 Diseases of myoneural junction and muscle	0.727	0.273	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.726	0.274	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.725	0.274	0.000
Y45.8 Other analgesics and antipyretics	0.724	0.275	0.000
Z51.6 Desensitisation to allergens	0.723	0.277	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.722	0.278	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.721	0.279	0.000
A46 Erysipelas	0.721	0.279	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.721	0.279	0.000
Z45 Adjustment and management of implanted device	0.721	0.279	0.000
B00 Herpesviral [herpes simplex] infections	0.720	0.280	0.000
G00 Bacterial meningitis, not elsewhere classified	0.717	0.283	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.717	0.283	0.000
Y48 Anaesthetics and therapeutic gases	0.717	0.283	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283	0.000
Y35-Y36 Legal intervention and operations of war	0.717	0.283	0.000
Y10-Y34 Event of undetermined intent	0.717	0.283	0.000
X85-X99 Assault	0.717	0.283	0.000
X30-X39 Exposure to forces of nature	0.717	0.283	0.000
X00-X09 Exposure to smoke, fire and flames	0.717	0.283	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.717	0.283	0.000
W75-W84 Other accidental threats to breathing	0.717	0.283	0.000
W65-W74 Accidental drowning and submersion	0.717	0.283	0.000
V98-V99 Other and unspecified transport accidents	0.717	0.283	0.000
V95-V97 Air and space transport accidents	0.717	0.283	0.000
V90-V94 Water transport accidents	0.717	0.283	0.000
V70-V79 Bus occupant injured in transport accident	0.717	0.283	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.717	0.283	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.717	0.283	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.717	0.283	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.716	0.284	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.716	0.284	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.716	0.284	0.000
Z43.1 Attention to gastrostomy	0.714	0.286	0.000
Z71.6 Tobacco abuse counselling	0.713	0.287	0.000
W55 Bitten or struck by other mammals	0.712	0.287	0.000
Q54 Hypospadias	0.712	0.288	0.000
B85-B89 Pediculosis, acariasis and other infestations	0.711	0.289	0.000
B50-B64 Protozoal diseases	0.711	0.289	0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.711	0.289	0.000
A75-A79 Rickettsioses	0.711	0.289	0.000
A70-A74 Other diseases caused by chlamydiae	0.711	0.289	0.000
A65-A69 Other spirochaetal diseases	0.711	0.289	0.000
A20-A28 Certain zoonotic bacterial diseases	0.711	0.289	0.000
A15-A19 Tuberculosis	0.711	0.289	0.000
Y59 Other and unspecified vaccines and biological substances	0.710	0.290	0.000
Y58 Bacterial vaccines	0.710	0.290	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.710	0.290	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.710	0.290	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.710	0.290	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.710	0.290	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.710	0.290	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.710	0.290	0.000
I09 Other rheumatic heart diseases	0.710	0.290	0.000
I61.5 Intracerebral haemorrhage, intraventricular	0.710	0.290	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.708	0.292	0.000
C94 Other leukaemias of specified cell type	0.708	0.292	0.000
C93 Monocytic leukaemia	0.708	0.292	0.000
C88 Malignant immunoproliferative diseases	0.708	0.292	0.000
C86 Other specified types of T/NK-cell lymphoma	0.708	0.292	0.000
B65-B83 Helminthiases	0.708	0.292	0.000
D80-D89 Certain disorders involving the immune mechanism	0.707	0.293	0.000
Z54 Convalescence	0.706	0.294	0.000
G44.0 Cluster headache syndrome	0.706	0.294	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.706	0.294	0.000
Y45.5 4-Aminophenol derivatives	0.706	0.294	0.000
Y45.4 Antirheumatics	0.706	0.294	0.000
Z73.8 Other problems related to life-management difficulty	0.705	0.295	0.000
Z46.5 Fitting and adjustment of ileostomy and other intestinal appliances	0.704	0.296	0.000
Z50.6 Orthoptic training	0.703	0.297	0.000
Z50.3 Drug rehabilitation	0.703	0.297	0.000
Z51.4 Preparatory care for treatment, not elsewhere classified	0.703	0.297	0.000
X20-X29 Contact with venomous animals and plants	0.703	0.297	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.702	0.298	0.000
G82.1 Spastic paraplegia	0.702	0.298	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.701	0.299	0.000
Q21.1 Atrial septal defect	0.700	0.300	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.700	0.300	0.000
Z46.8 Fitting and adjustment of other specified devices	0.699	0.301	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.699	0.301	0.000
Z73.6 Limitation of activities due to disability	0.699	0.301	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.699	0.301	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.699	0.301	0.000
C92.0 Acute myeloid leukaemia	0.699	0.301	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.698	0.301	0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.698	0.302	0.000
C15-C26 Malignant neoplasms of digestive organs	0.696	0.304	0.000
Y52 Agents primarily affecting the cardiovascular system	0.695	0.305	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.695	0.305	0.000
Q35-Q37 Cleft lip and cleft palate	0.695	0.305	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.695	0.305	0.000
C81 Hodgkin's disease	0.694	0.305	0.000
Z76 Persons encountering health services in other circumstances	0.694	0.306	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.693	0.306	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.692	0.308	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.692	0.308	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.690	0.310	0.000
I00-I02 Acute rheumatic fever	0.689	0.311	0.000
C82.6 Cutaneous follicle centre lymphoma	0.689	0.311	0.000
C82.5 Diffuse follicle centre lymphoma	0.689	0.311	0.000
C82.4 Follicular lymphoma grade IIIb	0.689	0.311	0.000
C82.3 Follicular lymphoma grade IIIa	0.689	0.311	0.000
C82.2 Large cell, follicular	0.689	0.311	0.000
C82.0 Small cleaved cell, follicular	0.689	0.311	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.688	0.312	0.000
Z42 Follow-up care involving plastic surgery	0.686	0.314	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.685	0.315	0.000
I61.8 Other intracerebral haemorrhage	0.684	0.316	0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.684	0.316	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.683	0.317	0.000
G46 Vascular syndromes of brain in cerebrovascular diseases	0.683	0.317	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.681	0.319	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.681	0.319	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.679	0.321	0.000
Q55 Other congenital malformations of male genital organs	0.677	0.322	0.000
G81.1 Spastic hemiplegia	0.677	0.323	0.000
G81.0 Flaccid hemiplegia	0.677	0.323	0.000
B06 Rubella [German measles]	0.676	0.324	0.000
B05 Measles	0.676	0.324	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.676	0.324	0.000
B04 Monkeypox	0.676	0.324	0.000
B03 Smallpox	0.676	0.324	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.676	0.324	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.676	0.324	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.676	0.324	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.676	0.324	0.000
Q25 Congenital malformations of great arteries	0.676	0.324	0.000
I67.9 Cerebrovascular disease, unspecified	0.676	0.324	0.000
Z75.5 Holiday relief care	0.676	0.324	0.000
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.675	0.324	0.000
Y44 Agents primarily affecting blood constituents	0.675	0.325	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.675	0.325	0.000
I67.1 Cerebral aneurysm, nonruptured	0.674	0.326	0.000
Z70 Counselling related to sexual attitude, behaviour and orientation	0.674	0.326	0.000
B07 Viral warts	0.672	0.328	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.672	0.328	0.000
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.668	0.332	0.000
I05.1 Rheumatic mitral insufficiency	0.668	0.332	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.668	0.332	0.000
A50-A64 Infections with a predominantly sexual mode of transmission	0.667	0.332	0.000
B02.9 Zoster without complication	0.667	0.333	0.000
G83.9 Paralytic syndrome, unspecified	0.667	0.333	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.666	0.333	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.666	0.333	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.666	0.333	0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.666	0.333	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.666	0.333	0.000
Y89 Sequelae of other external causes	0.666	0.333	0.000
S90-S99 Injuries to the ankle and foot	0.666	0.334	0.000
D00-D09 In situ neoplasms	0.664	0.335	0.001
Y57.5 X-ray contrast media	0.665	0.335	0.000
S10-S19 Injuries to the neck	0.664	0.336	0.000
I06 Rheumatic aortic valve diseases	0.661	0.339	0.000
X51 Travel and motion	0.660	0.339	0.000
B96.2 Escherichia coli [E. coli] as the cause of diseases classified to other chapters	0.661	0.339	0.000
Q53 Undescended testicle	0.660	0.340	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.658	0.342	0.000
W25 Contact with sharp glass	0.658	0.342	0.000
Z44 Fitting and adjustment of external prosthetic device	0.657	0.343	0.000
D86 Sarcoidosis	0.657	0.343	0.000
G30-G32 Other degenerative diseases of the nervous system	0.656	0.344	0.000
B25.9 Cytomegaloviral disease, unspecified	0.655	0.345	0.000
G40 Epilepsy	0.655	0.345	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.654	0.346	0.000
Q60-Q64 Congenital malformations of the urinary system	0.654	0.346	0.000
V10-V19 Pedal cyclist injured in transport accident	0.653	0.346	0.000
B90-B94 Sequelae of infectious and parasitic diseases	0.652	0.348	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.652	0.348	0.000
T20-T25 Burns and corrosions of external body surface, specified by site	0.651	0.349	0.000
B99-B99 Other infectious diseases	0.651	0.349	0.000
G83.2 Monoplegia of upper limb	0.651	0.349	0.000
B34 Viral infection of unspecified site	0.651	0.349	0.000
A39 Meningococcal infection	0.650	0.350	0.000
V20-V29 Motorcycle rider injured in transport accident	0.648	0.351	0.000
B96.8 Other specified bacterial agents as the cause of diseases classified to other chapters	0.647	0.353	0.000
Y79.2 Prosthetic and other implants, materials and accessory devices	0.646	0.353	0.000
G44.8 Other specified headache syndromes	0.645	0.354	0.000
G44.3 Chronic posttraumatic headache	0.645	0.354	0.000
G44.1 Vascular headache, not elsewhere classified	0.645	0.354	0.000
X12 Contact with other hot fluids	0.644	0.356	0.000
Z45.2 Adjustment and management of vascular access device	0.644	0.356	0.000
Y85.9 Sequelae of other and unspecified transport accidents	0.644	0.356	0.000
B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified to other chapters	0.643	0.357	0.000
B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified to other chapters	0.643	0.357	0.000
B15-B19 Viral hepatitis	0.643	0.357	0.000
C92.9 Myeloid leukaemia, unspecified	0.643	0.357	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.643	0.357	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.643	0.357	0.000
C92.5 Acute myelomonocytic leukaemia	0.643	0.357	0.000
C92.4 Acute promyelocytic leukaemia	0.643	0.357	0.000
C92.3 Myeloid sarcoma	0.643	0.357	0.000
C92.2 Subacute myeloid leukaemia	0.643	0.357	0.000
I67.2 Cerebral atherosclerosis	0.642	0.358	0.000
T92 Sequelae of injuries of upper limb	0.640	0.360	0.000
Y42.7 Androgens and anabolic congeners	0.640	0.360	0.000
G82.3 Flaccid tetraplegia	0.640	0.360	0.000
G82.0 Flaccid paraplegia	0.640	0.360	0.000
G36 Other acute disseminated demyelination	0.640	0.360	0.000
I05.8 Other mitral valve diseases	0.640	0.360	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.639	0.361	0.000
C80.9 Malignant neoplasm, unspecified	0.639	0.361	0.000
Y40 Systemic antibiotics	0.638	0.361	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.638	0.362	0.000
G83.8 Other specified paralytic syndromes	0.637	0.363	0.000
G83.5 Locked-in syndrome	0.637	0.363	0.000
G83.3 Monoplegia, unspecified	0.637	0.363	0.000
G83.0 Diplegia of upper limbs	0.637	0.363	0.000
Z51.9 Medical care, unspecified	0.636	0.364	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.635	0.365	0.000
Z40.9 Prophylactic surgery, unspecified	0.635	0.365	0.000
Q51 Congenital malformations of uterus and cervix	0.634	0.366	0.000
C91 Lymphoid leukaemia	0.634	0.366	0.000
G90-G99 Other disorders of the nervous system	0.633	0.367	0.000
G83.1 Monoplegia of lower limb	0.633	0.367	0.000
I05.2 Mitral stenosis with insufficiency	0.633	0.367	0.000
Q82 Other congenital malformations of skin	0.632	0.367	0.000
Y82 Other and unspecified medical devices associated with adverse incidents	0.632	0.368	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.632	0.368	0.000
Y80 Physical medicine devices associated with adverse incidents	0.632	0.368	0.000
Y78 Radiological devices associated with adverse incidents	0.632	0.368	0.000
Y77 Ophthalmic devices associated with adverse incidents	0.632	0.368	0.000
Y75 Neurological devices associated with adverse incidents	0.632	0.368	0.000
Y74 General hospital and personal-use devices associated with adverse incidents	0.632	0.368	0.000
Y73 Gastro-enterology and urology devices associated with adverse incidents	0.632	0.368	0.000
Y72 Otorhinolaryngological devices associated with adverse incidents	0.632	0.368	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.632	0.368	0.000
Y70 Anaesthesiology devices associated with adverse incidents	0.632	0.368	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.632	0.368	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.629	0.371	0.000
W59 Bitten or crushed by other reptiles	0.629	0.371	0.000
W58 Bitten or struck by crocodile or alligator	0.629	0.371	0.000
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.629	0.371	0.000
W56 Contact with marine animal	0.629	0.371	0.000
W54 Bitten or struck by dog	0.629	0.371	0.000
W53 Bitten by rat	0.629	0.371	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.629	0.371	0.000
W51 Striking against or bumped into by another person	0.629	0.371	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.629	0.371	0.000
Z43.5 Attention to cyctostomy	0.626	0.374	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.626	0.374	0.000
G82.2 Paraplegia, unspecified	0.625	0.375	0.000
Y04 Assault by bodily force	0.625	0.375	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.625	0.375	0.000
Q18 Other congenital malformations of face and neck	0.623	0.376	0.000
C25 Malignant neoplasm of pancreas	0.623	0.377	0.000
V48 Car occupant injured in noncollision transport accident	0.623	0.377	0.000
Z74 Problems related to care-provider dependency	0.622	0.377	0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.5 Reovirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.622	0.378	0.000
X78 Intentional self-harm by sharp object	0.621	0.379	0.000
B02.3 Zoster ocular disease	0.620	0.380	0.000
S80-S89 Injuries to the knee and lower leg	0.619	0.381	0.000
I63.8 Other cerebral infarction	0.619	0.381	0.000
G47.2 Disorders of the sleep-wake schedule	0.619	0.381	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.618	0.382	0.000
V88 Nontraffic accident of specified type but victim's mode of transport unknown	0.617	0.382	0.000
V87 Traffic accident of specified type but victim's mode of transport unknown	0.617	0.382	0.000
V86 Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident	0.617	0.382	0.000
V85 Occupant of special construction vehicle injured in transport accident	0.617	0.382	0.000
V84 Occupant of special vehicle mainly used in agriculture injured in transport accident	0.617	0.382	0.000
V83 Occupant of special vehicle mainly used on industrial premises injured in transport accident	0.617	0.382	0.000
V82 Occupant of streetcar injured in transport accident	0.617	0.382	0.000
V81 Occupant of railway train or railway vehicle injured in transport accident	0.617	0.382	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.617	0.383	0.000
G20-G26 Extrapyramidal and movement disorders	0.616	0.384	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.616	0.384	0.000
Z51.8 Other specified medical care	0.616	0.384	0.000
S50-S59 Injuries to the elbow and forearm	0.615	0.385	0.000
Y57.9 Drug or medicament, unspecified	0.614	0.386	0.000
Y00 Assault by blunt object	0.614	0.386	0.000
Z42.0 Follow-up care involving plastic surgery of head and neck	0.613	0.387	0.000
Z52.8 Donor of other organs and tissues	0.613	0.387	0.000
Q56 Indeterminate sex and pseudohermaphroditism	0.613	0.387	0.000
Q52 Other congenital malformations of female genitalia	0.613	0.387	0.000
B33 Other viral diseases, not elsewhere classified	0.613	0.387	0.000
B30 Viral conjunctivitis	0.613	0.387	0.000
B27 Infectious mononucleosis	0.613	0.387	0.000
B26 Mumps	0.613	0.387	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.612	0.388	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.611	0.388	0.000
A40 Streptococcal septicaemia	0.611	0.389	0.000
B02.2 Zoster with other nervous system involvement	0.611	0.389	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.610	0.390	0.000
S70-S79 Injuries to the hip and thigh	0.610	0.390	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.610	0.390	0.000
W60.0 Home	0.609	0.391	0.000
Z40.8 Other prophylactic surgery	0.608	0.392	0.000
Chapter XXII Codes for special purposes	0.605	0.395	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.604	0.395	0.000
V01 Pedestrian injured in collision with pedal cycle	0.604	0.396	0.000
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.603	0.397	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.603	0.397	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.603	0.397	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.603	0.397	0.000
I65.1 Occlusion and stenosis of basilar artery	0.603	0.397	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.603	0.397	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.603	0.397	0.000
Z75.8 Other problems related to medical facilities and other health care	0.603	0.397	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.603	0.397	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.603	0.397	0.000
Z75.2 Other waiting period for investigation and treatment	0.603	0.397	0.000
Z75.0 Medical services not available in home	0.603	0.397	0.000
Q26 Congenital malformations of great veins	0.603	0.397	0.000
Q24 Other congenital malformations of heart	0.603	0.397	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.603	0.397	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.603	0.397	0.000
Z53 Persons encountering health services for specifie procedures, not carried out	0.602	0.398	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.602	0.398	0.000
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.601	0.398	0.000
B08.5 Enteroviral vesicular pharyngitis	0.601	0.398	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.601	0.398	0.000
B08.3 Erythema infectiosum [fifth disease]	0.601	0.398	0.000
B08.2 Exanthema subitum [sixth disease]	0.601	0.398	0.000
B08.0 Other orthopoxvirus infections	0.601	0.398	0.000
I07.1 Tricuspid insufficiency	0.601	0.398	0.000
Z73.5 Social role conflict, not elsewhere classified	0.601	0.399	0.000
Z73.4 Inadequate social skills, not elsewhere classified	0.601	0.399	0.000
Z73.2 Lack of relaxation and leisure	0.601	0.399	0.000
Z73.1 Accentuation of personality traits	0.601	0.399	0.000
Z73.0 Burn-out	0.601	0.399	0.000
A41 Other septicaemia	0.601	0.399	0.000
C90.0 Multiple myeloma	0.600	0.400	0.000
Z52.3 Bone marrow donor	0.600	0.400	0.000
W00-W19 Falls	0.599	0.401	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.599	0.401	0.000
A48 Other bacterial diseases, not elsewhere classified	0.598	0.402	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.598	0.402	0.000
D03 Melanoma in situ	0.598	0.402	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.598	0.402	0.000
Y85.0 Sequelae of motor-vehicle accident	0.597	0.403	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.597	0.403	0.000
Q28 Other congenital malformations of circulatory system	0.596	0.403	0.000
W44 Foreign body entering into or through eye or natural orifice	0.596	0.403	0.000
I62 Other nontraumatic intracranial haemorrhage	0.596	0.404	0.000
W55.0 Home	0.594	0.406	0.000
G80.9 Infantile cerebral palsy, unspecified	0.593	0.407	0.000
C21 Malignant neoplasm of anus and anal canal	0.593	0.407	0.000
Y52.1 Calcium-channel blockers	0.590	0.410	0.000
Y43.0 Antiallergic and antiemetic drugs	0.590	0.410	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations